transcript · 38,721 words

Novo Nordisk (Ozempic)

Transcribed with NVIDIA Parakeet · Timestamps stay in sync with the live audio

Alright, first episode back. Let's see if I can do this sleep deprived. Oh, you and me both, man. Who got the truth? Is it you, is it you, is it you Who got

No Is it you, is it you, is it you? Let me down Another story on the way Got the truth.

Welcome to season fourteen, episode one of Acquired, the podcast about great companies and the stories and playbooks behind them. I'm Ben Gilbert. I'm David Resenthal. And we are your hosts. Today's episode is on the company behind these sensational diabetes and weight loss drugs, Ozempic and WeGovi. The company.

That is the first couple of minutes. The rest is $1.

We already have this episode, so unlocking it is cheap and permanent: the full transcript, segment and word-level timestamps, and .txt, .srt, .vtt and word-level JSON downloads, as many times as you like, forever.

Have credits? Log in See plans

No account needed, we create one from your checkout email. With credits it is 1 credit; packs start at 10 episodes for $5, and monthly plans are cheaper still.

get it now

Ready in about two minutes.

Pay once, no subscription. Credits never expire.

Transcribing every week? Monthly plans start at $9, about 23 cents an episode.

Secure checkout by Stripe. No account needed: we create one from your email. By paying you agree to the terms.